ICC International Cannabis Corp. announced that further to the signed Letter of Intent with Wayland Group Corp., the companies will begin integration of its extraction and distillation processes, in addition to finished dose manufacturing of CBD products for the European market. Wayland's 125,000 kg supply of CBD flowers for extraction will be processed in International Cannabis' Polannabis operations and finished into distillate.

Leveraging Wayland's patented Vesisorb formulations, Cosmos Holdings will then manufacture finished dose CBD products, including oral tablets in its EU-GMP certified facilities in Greece. Wayland's patented Vesisorb formulations have been demonstrated to increase absorption of fat-soluble drugs by up to seven times, compared to those without. The expedited integration of operations, to take advantage of Wayland's existing supply and ICC's EU-GMP certified operations for finished dose manufacturing will lead to efficiencies in production, and dramatically reduce cost of goods; boosting profitability.

The expedited nature of the operational integration increases speed to market and takes advantage of Cosmos' vast existing distribution channels.